- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02520401
The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This studies aims to investigate the effect of a probiotics in peri-implantitis patients as an adjunct to non-surgical therapy.
Study design: This study will be a single centre (Department of Oral Health Sciences, University Hospitals Leuven), double blind randomized, placebo controlled clinical trial. The randomization (by means of a computer program) and double blind design are thought to minimize the bias of the investigator and patients.
Selection of the study population: Adults, who consult at the departement of Periodontology at the University Hospital Leuven, with peri-implantitis and who fit the inclusion criteria will be asked to participate in this study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3000
- UZLeuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- >18 years of age
- Patients with at least one implant* diagnosed with initial peri-implantitis.
- Willing and able to give written informed consent
- No signs of acute periodontitis
- presence of keratinized tissue around treated implant(s)
Exclusion Criteria:
- patients who smoke
- patients with periodontitis
- pregnant or lactating woman
- patients with poorly controlled diabetes
- patients taking bisphosphonate mediation
- patient who had taken systemic antibiotics 3 months prior to treatment
- peri-implantitis treatment 12 months prior intake
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test
Probiotic tablet
|
Use of a probiotic tablet
|
Placebo Comparator: Control
Control tablet
|
Use of a placebo tablet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Probing Pocket Depth (PPD) at peri-implantitis sites
Time Frame: Baseline - 6 months
|
Pocket probing depth measured with Merrit-B probe
|
Baseline - 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bleeding on Probing (BoP) at peri-implantitis sites
Time Frame: Baseline - 6 months
|
Binairy outcome: 0: no bleeding, 1: bleeding
|
Baseline - 6 months
|
Plaque at peri-implantitis sites
Time Frame: Baseline - 6 months
|
Binairy outcome: 0: no plaque, 1: plaque
|
Baseline - 6 months
|
Microbial samples
Time Frame: Baseline - 6 months
|
Of tongue coating, saliva and peri-implantitis site
|
Baseline - 6 months
|
Full mouth plaque score (FMPS)
Time Frame: Baseline - 6 months
|
Binairy outcome: 0: no plaque, 1: plaque
|
Baseline - 6 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- s57668
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
University of ManitobaUnknownPeri ImplantitisCanada
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusRecruitingDental Implants,Peri-implantitis,SmokingIsrael
-
Tuğba ŞAHİNCompletedPeri-Implantitis, Peri-implant MucositisTurkey
-
Proed, Torino, ItalyCompleted
-
University of ZagrebNot yet recruitingPeri-implant Mucositis | Peri-Implantitis and Peri-implant Mucositis | Peri-implant Health | Periimplant Diseases | Periimplant Bone Loss
-
National and Kapodistrian University of AthensRecruitingPeri-Implantitis | Peri-Implant HealthGreece
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
University of BaghdadRecruiting
Clinical Trials on Probiotic - BioGaia
-
Universitaire Ziekenhuizen KU LeuvenBioGaia ABCompleted
-
BioGaia ABCompletedDysbiosis | ProphylaxisRussian Federation
-
University of CopenhagenCompletedRecurrent Aphthous UlcersDenmark
-
Tulane University School of MedicineJohns Hopkins Bloomberg School of Public Health; National Center for Complementary... and other collaboratorsCompleted
-
Tulane University School of MedicineJohns Hopkins Bloomberg School of Public Health; National Center for Complementary... and other collaboratorsCompleted
-
Colombian Neonatal Research NetworkVanderbilt University; Instituto Colombiano para el Desarrollo de la Ciencia...Terminated
-
The Hospital for Sick ChildrenCompleted
-
Case Western Reserve UniversityBioGaia ABCompletedAntibiotic-associated Diarrhea | Clostridium DifficileUnited States
-
Trisakti UniversityIndonesia University; Duke-NUS Graduate Medical School; BioGaia ABActive, not recruitingHealthy Subjects With Fixed OrthodonticsIndonesia
-
The Hospital for Sick ChildrenUnknownColic | Infantile